Dupilumab Subcutaneous and Quillivant XR
Determining the interaction of Dupilumab Subcutaneous and Quillivant XR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: methylphenidate
Brand name: QuilliChew ER, Quillivant XR, Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate ER, Methylin, Relexxii, Ritalin, Ritalin LA, Metadate CD, Ritalin SR, Daytrana, Methylin ER
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Quin-G
- Dupilumab Subcutaneous-Quinaglute
- Dupilumab Subcutaneous-Quinalan
- Dupilumab Subcutaneous-Quinamm
- Dupilumab Subcutaneous-Quinapril
- Dupilumab Subcutaneous-Quinapril and Hydrochlorothiazide
- Quillivant XR-Dupixent
- Quillivant XR-Duplex T Topical
- Quillivant XR-Durachol
- Quillivant XR-Duraclon
- Quillivant XR-Duraclon injection
- Quillivant XR-Duraflu